Literature DB >> 19079071

Protein-protein interactions as therapeutic targets in neuropsychopharmacology.

Matthew T Reilly1, Kathryn A Cunningham, Amarnath Natarajan.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19079071     DOI： 10.1038/npp.2008.167

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN： 0893-133X            Impact factor:   7.853


× No keyword cloud information.
  7 in total

Review 1.  MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

Authors:  Andrea de Bartolomeis; Felice Iasevoli; Carmine Tomasetti; Elisabetta F Buonaguro
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

Review 2.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

3.  Protein interface remodeling in a chemically induced protein dimer.

Authors:  Brian R White; Jonathan C T Carlson; Jessie L Kerns; Carston R Wagner
Journal:  J Mol Recognit       Date:  2012-07       Impact factor: 2.137

4.  Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.

Authors:  Ashley T Fancher; Yun Hua; Daniel P Camarco; David A Close; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2016-09-08       Impact factor: 1.738

5.  High-content positional biosensor screening assay for compounds to prevent or disrupt androgen receptor and transcriptional intermediary factor 2 protein-protein interactions.

Authors:  Yun Hua; Tong Ying Shun; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2014-09       Impact factor: 1.738

Review 6.  Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.

Authors:  A de Bartolomeis; E F Buonaguro; F Iasevoli
Journal:  Psychopharmacology (Berl)       Date:  2012-11-21       Impact factor: 4.530

7.  NOGEA: A Network-oriented Gene Entropy Approach for Dissecting Disease Comorbidity and Drug Repositioning.

Authors:  Zihu Guo; Yingxue Fu; Chao Huang; Chunli Zheng; Ziyin Wu; Xuetong Chen; Shuo Gao; Yaohua Ma; Mohamed Shahen; Yan Li; Pengfei Tu; Jingbo Zhu; Zhenzhong Wang; Wei Xiao; Yonghua Wang
Journal:  Genomics Proteomics Bioinformatics       Date:  2021-03-17       Impact factor: 6.409
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.